1. Cardiovascular risk reduction: What do recent trials with rosuvastatin tell us?

   • Gianna Fabbri
   • Aldo Pietro Maggioni

   Review 14 May 2009 Pages: 469 - 487

2. Saxagliptin: a new dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes

   • Carolyn F. Deacon
   • Jens J. Holst

   Review 14 May 2009 Pages: 488 - 499

3. The role of eszopiclone in the treatment of insomnia

   • Anna K. Morin
   • Kristine Willett

   Review 02 June 2009 Pages: 500 - 518

4. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation

   • Jeremy D. Gale

   Review 14 May 2009 Pages: 519 - 530

5. Investigation of a multimarker approach to the initial assessment of patients with acute chest pain

   • C. J. McCann
   • B. M. Glover
   • J. A. Adgey

   Review 27 May 2009 Pages: 531 - 534

6. Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE

   • Pierre Fontaine
   • Henri Gin
   • Srishyla Venkatanarasimhachar

   Original Research 02 June 2009 Pages: 535 - 551

7. Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis

   • Jane Castelli-Haley
   • MerriKay A. Oleen-Burkey
   • Kenneth P. Johnson

   Original Research 14 May 2009 Pages: 552 - 562

8. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial

   • N. Bresolin
   • C. Zucca
   • A. Pecori

   Original Research 20 May 2009 Pages: 563 - 573